ViroGates A/S Sustainability Reports

ViroGates A/S develops and markets blood test products under the suPARnostic brand to measure chronic inflammation for triaging in hospitals and healthcare settings.

Sector: Manufacturing

Country: Denmark

Exchange: Nasdaq Copenhagen

LEI: 5493007TX8XS56RMZD94

FIGI: BBG00L2R5H44

8 reports from 2018 to 2025

• ViroGates A/S 2025 Annual Report
• ViroGates A/S 2024 Annual Report
• ViroGates A/S 2023 Annual Report
• ViroGates A/S 2022 Annual Report
• ViroGates A/S 2021 Annual Report